Home/Filings/4/0001209191-19-024055
4//SEC Filing

Perone Thomas Michael 4

Accession 0001209191-19-024055

CIK 0001636651other

Filed

Apr 7, 8:00 PM ET

Accepted

Apr 8, 8:30 PM ET

Size

5.5 KB

Accession

0001209191-19-024055

Insider Transaction Report

Form 4
Period: 2019-04-03
Perone Thomas Michael
SVP, General Counsel
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2019-04-03+125,000125,000 total
    Exercise: $1.92Exp: 2029-03-24Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the Stock Option will vest and become exercisable on March 25, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0001771761

Filing Metadata

Form type
4
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 8:30 PM ET
Size
5.5 KB